These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27878254)

  • 1. Restoration of the tumor-suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells.
    Jiang D; Wang L; Zhao T; Zhang Z; Zhang R; Jin J; Cai Y; Wang F
    Oncol Rep; 2017 Jan; 37(1):594-600. PubMed ID: 27878254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor or promoter? The performance of polysaccharides from Ganoderma lucidum on human tumor cells with different p53 statuses.
    Zhang J; Chen JM; Wang XX; Xia YM; Cui SW; Li J; Ding ZY
    Food Funct; 2016 Apr; 7(4):1872-5. PubMed ID: 26999513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo.
    Na K; Li K; Sang T; Wu K; Wang Y; Wang X
    Int J Oncol; 2017 May; 50(5):1541-1554. PubMed ID: 28358412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of migration and induction of apoptosis in LoVo human colon cancer cells by polysaccharides from Ganoderma lucidum.
    Liang ZE; Yi YJ; Guo YT; Wang RC; Hu QL; Xiong XY
    Mol Med Rep; 2015 Nov; 12(5):7629-36. PubMed ID: 26397202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells.
    Li YB; Wang R; Wu HL; Li YH; Zhong LJ; Yu HM; Li XJ
    Oncol Rep; 2008 Sep; 20(3):549-56. PubMed ID: 18695905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
    Wu X; Lu Y; Qin X
    J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities.
    Xu Z; Chen X; Zhong Z; Chen L; Wang Y
    Am J Chin Med; 2011; 39(1):15-27. PubMed ID: 21213395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity.
    Xu F; Li X; Xiao X; Liu LF; Zhang L; Lin PP; Zhang SL; Li QS
    Biomed Pharmacother; 2017 Nov; 95():504-512. PubMed ID: 28866417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
    Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
    Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
    Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
    Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacological Rationales and Molecular Mechanisms of
    Luo H; Tan D; Peng B; Zhang S; Vong CT; Yang Z; Wang Y; Lin Z
    Am J Chin Med; 2022; 50(1):53-90. PubMed ID: 34963429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo.
    Li K; Na K; Sang T; Wu K; Wang Y; Wang X
    Oncol Rep; 2017 Nov; 38(5):2803-2813. PubMed ID: 29048673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.
    McDermott U; Longley DB; Galligan L; Allen W; Wilson T; Johnston PG
    Cancer Res; 2005 Oct; 65(19):8951-60. PubMed ID: 16204068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo.
    Opattova A; Horak J; Vodenkova S; Kostovcikova K; Cumova A; Macinga P; Galanova N; Rejhova A; Vodickova L; Kozics K; Turnovcova K; Hucl T; Sliva D; Vodicka P
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep; 845():403065. PubMed ID: 31561886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.
    Cui B; Yang Q; Guan H; Shi B; Hou P; Ji M
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E962-70. PubMed ID: 24512488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
    PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganoderma lucidum polysaccharides inhibit in vitro tumorigenesis, cancer stem cell properties and epithelial-mesenchymal transition in oral squamous cell carcinoma.
    de Camargo MR; Frazon TF; Inacio KK; Smiderle FR; Amôr NG; Dionísio TJ; Santos CF; Rodini CO; Lara VS
    J Ethnopharmacol; 2022 Mar; 286():114891. PubMed ID: 34910952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoic acid induces p53-independent cell death in colorectal cancer cells and potentiates the cytotoxicity of 5-fluorouracil.
    Dörsam B; Göder A; Seiwert N; Kaina B; Fahrer J
    Arch Toxicol; 2015 Oct; 89(10):1829-46. PubMed ID: 25526924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.